What are the risks of investing in TVGN?
T
What are the risks of investing in TVGN?
🦉
Tevogen Bio Holdings Inc. (TVGN)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEORyan H. Saadi
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19...
Key Executives
| Name | Title |
|---|---|
| David E. Banko | Global Head of Government Affairs & Patient Access |
| Kirti Desai | Chief Financial Officer |
| Mittul Mehta | Chief Information Officer & Head of Tevogen.ai |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead |
| Ryan H. Saadi | Co-Founder, Chief Executive Officer & Chairperson |
| Sadiq Khan | Chief Commercial Officer & Interim Head of Tevogen Generics |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A